AbbVie Corp. v. Janssen Inc., [2014] F.T.R. Uned. 23 (FC)
| Judge | Hughes, J. |
| Court | Federal Court (Canada) |
| Case Date | January 17, 2014 |
| Jurisdiction | Canada (Federal) |
| Citations | [2014] F.T.R. Uned. 23 (FC);2014 FC 55;[2014] F.T.R. Uned. 23 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
33 practice notes
-
Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)
...- see Pfizer Canada Inc. et al. v. Novopharm Ltd. et al. AbbVie Corp. et al. v. Janssen Inc., [2014] F.T.R. Uned. 23; 116 C.P.R.(4th) 399; 2014 FC 55, revd. [2014] N.R. Uned. 142; 2014 FCA 242, refd to. [para. Leithiser and Timberland Ellicott Ltd. v. Pengo Hydra-Pull of Canada Ltd., [1974]......
-
Alcon Canada Inc. et al. v. Apotex Inc. et al., (2014) 461 F.T.R. 259 (FC)
...et al., [2008] 3 S.C.R. 265; 381 N.R. 125; 2008 SCC 61, appld. [para. 163]. AbbVie Corp. et al. v. Janssen Inc., [2014] F.T.R. Uned. 23; 2014 FC 55, refd to. [para. 164]. Pozzoli SPA v BDMO SA, [2007] FSR 37; [2007] EWCA Civ 588 (BAILII), refd to. [para. 202]. Pfizer Canada Inc. et al. v. A......
-
Angelcare Canada Inc. v. Munchkin, Inc., 2022 FC 507
...a repetition of the claims construction exercise (Shire, para 74). Additionally, Justice Hughes warns in Abbvie Corporation v Janssen Inc, 2014 FC 55 at paragraph 123 (rev’d on other grounds 2014 FCA 242) that “[t]he Court is required to focus on the invention as claimed in the claims at is......
-
AbbVie Corp. et al. v. Janssen Inc., (2014) 461 N.R. 253 (FCA)
.... Janssen has appealed that refusal (file A-380-13). [5] Following a trial on the liability phase, the Federal Court found infringement: 2014 FC 55. Janssen has appealed that finding (file A-95-14). [6] After the Federal Court's finding of liability, it embarked upon the remedial phase. Fir......
Request a trial to view additional results
11 cases
-
Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2015) 474 N.R. 311 (FCA)
...- see Pfizer Canada Inc. et al. v. Novopharm Ltd. et al. AbbVie Corp. et al. v. Janssen Inc., [2014] F.T.R. Uned. 23; 116 C.P.R.(4th) 399; 2014 FC 55, revd. [2014] N.R. Uned. 142; 2014 FCA 242, refd to. [para. Leithiser and Timberland Ellicott Ltd. v. Pengo Hydra-Pull of Canada Ltd., [1974]......
-
Alcon Canada Inc. et al. v. Apotex Inc. et al., (2014) 461 F.T.R. 259 (FC)
...et al., [2008] 3 S.C.R. 265; 381 N.R. 125; 2008 SCC 61, appld. [para. 163]. AbbVie Corp. et al. v. Janssen Inc., [2014] F.T.R. Uned. 23; 2014 FC 55, refd to. [para. 164]. Pozzoli SPA v BDMO SA, [2007] FSR 37; [2007] EWCA Civ 588 (BAILII), refd to. [para. 202]. Pfizer Canada Inc. et al. v. A......
-
Angelcare Canada Inc. v. Munchkin, Inc., 2022 FC 507
...a repetition of the claims construction exercise (Shire, para 74). Additionally, Justice Hughes warns in Abbvie Corporation v Janssen Inc, 2014 FC 55 at paragraph 123 (rev’d on other grounds 2014 FCA 242) that “[t]he Court is required to focus on the invention as claimed in the claims at is......
-
AbbVie Corp. et al. v. Janssen Inc., (2014) 461 N.R. 253 (FCA)
.... Janssen has appealed that refusal (file A-380-13). [5] Following a trial on the liability phase, the Federal Court found infringement: 2014 FC 55. Janssen has appealed that finding (file A-95-14). [6] After the Federal Court's finding of liability, it embarked upon the remedial phase. Fir......
Request a trial to view additional results
22 firm's commentaries
-
Canadian Patent Law: 2014 Year In Review
...dealing specifically with pharmaceutical patent cases: Biologic patent infringement action: in Abbvie Corporation v. Janssen Inc., 2014 FC 55, the Federal Court found Abbvie's patent related to human antibodies to be valid and infringed. It was the first biologics patent decision of the Cou......
-
Appeal Decision Addresses the Promise Doctrine (Intellectual Property Weekly Abstracts Bulletin - Week Of November 3rd, 2014)
...and in the result, has sent the matter back down for re-hearing. One appeal related to the finding that the patent was valid and infringed (2014 FC 55). A second appeal related to the Federal Court's dismissal of Janssen's pre-trial motion to amend Schedule A to its Defence and Counterclaim......
-
Court Of Appeal Permits Janssen To Amend Its Plea, Dissolves STELARA Injunction And Orders New Trial
...AbbVie's patent for the use of an antibody with certain characteristics for the treatment of psoriasis, and that the patent was valid (2014 FC 55). Following a second trial, Justice Hughes granted AbbVie an injunction (2014 FC 489), reported in the June 2014 edition of Rx IP On October 28, ......
-
The Top 5 Trends In Canadian Intellectual Property Law For 2015
...The only case in the last 15 years litigated to a decision (now vacated, and never to be heard again) is Abbvie Corp v Janssen Inc, 2014 FC 55 rev'd 2014 FCA 242. Abbvie owns a patent pertaining to human antibodies and their use in treating autoimmune diseases. Janssen produces a human mono......
Request a trial to view additional results